Natural proteasome inhibitor celastrol suppresses androgen-independent prostate cancer progression by modulating apoptotic proteins and NF-kappaB
about
13-methyltetradecanoic acid exhibits anti-tumor activity on T-cell lymphomas in vitro and in vivo by down-regulating p-AKT and activating caspase-3Triptolide inhibits the proliferation of prostate cancer cells and down-regulates SUMO-specific protease 1 expressionUpregulating Noxa by ER stress, celastrol exerts synergistic anti-cancer activity in combination with ABT-737 in human hepatocellular carcinoma cellsA high throughput screen for RGS proteins using steady state monitoring of free phosphate formationCelastrol suppresses tumor cell growth through targeting an AR-ERG-NF-κB pathway in TMPRSS2/ERG fusion gene expressing prostate cancerNF-kappa B modulation is involved in celastrol induced human multiple myeloma cell apoptosisChronic inflammation and cancer: potential chemoprevention through nuclear factor kappa B and p53 mutual antagonismCelastrol stimulates hypoxia-inducible factor-1 activity in tumor cells by initiating the ROS/Akt/p70S6K signaling pathway and enhancing hypoxia-inducible factor-1α protein synthesis.Evaluation of anticancer activity of celastrol liposomes in prostate cancer cells.Celastrol, an oral heat shock activator, ameliorates multiple animal disease models of cell death.Celastrol decreases specificity proteins (Sp) and fibroblast growth factor receptor-3 (FGFR3) in bladder cancer cells.Effect of cell-penetrating peptide-coated nanostructured lipid carriers on the oral absorption of tripterineCelastrol Ameliorates Ulcerative Colitis-Related Colorectal Cancer in Mice via Suppressing Inflammatory Responses and Epithelial-Mesenchymal Transition.Targeting cancer cell mitochondria as a therapeutic approach.Epigenomic Regulation of Androgen Receptor Signaling: Potential Role in Prostate Cancer Therapy.Overcoming chemoresistance in prostate cancer with Chinese medicine Tripterygium wilfordii via multiple mechanisms.Design of novel BH3 mimetics for the treatment of chronic lymphocytic leukemia.Therapeutic targeting of cancer cell cycle using proteasome inhibitorsSynthesis and pharmacology of proteasome inhibitors.Apoptosis inducers in chronic lymphocytic leukemia.Cytotoxic effect of celastrol alone or in combination with paclitaxel on anaplastic thyroid carcinoma cells.Nanoencapsulation of natural triterpenoid celastrol for prostate cancer treatment.Celastrol induces unfolded protein response-dependent cell death in head and neck cancer.Antitumor activity of tripterine via cell-penetrating peptide-coated nanostructured lipid carriers in a prostate cancer model.Celastrol inhibits lipopolysaccharide-induced angiogenesis by suppressing TLR4-triggered nuclear factor-kappa B activation.Role of the eIF4E binding protein 4E-BP1 in regulation of the sensitivity of human pancreatic cancer cells to TRAIL and celastrol-induced apoptosis.Celastrol induced DNA damage, cell cycle arrest, and apoptosis in human rheumatoid fibroblast-like synovial cells.The extent of neurodegeneration and neuroprotection in two chemical in vitro models related to Parkinson's disease is critically dependent on cell culture conditions.CXCL1/GROα increases cell migration and invasion of prostate cancer by decreasing fibulin-1 expression through NF-κB/HDAC1 epigenetic regulation.Compounds From Celastraceae Targeting Cancer Pathways and Their Potential Application in Head and Neck Squamous Cell Carcinoma: A Review.Celastrol: A Spectrum of Treatment Opportunities in Chronic DiseasesProteasome inhibitors, including curcumin, improve pancreatic β-cell function and insulin sensitivity in diabetic mice.Celastrol inhibits migration and invasion through blocking the NF-κB pathway in ovarian cancer cells.Celastrol induces apoptosis in hepatocellular carcinoma cells via targeting ER-stress/UPR.Targeting the ubiquitin-proteasome system for cancer treatment: discovering novel inhibitors from nature and drug repurposing.Investigation of the influence of glycyrrhizin on the pharmacokinetics of celastrol in rats using LC-MS and its potential mechanism.Celastrol and Its Role in Controlling Chronic Diseases.Tumor growth attenuating effect of celastrol in systemic malignancies.Celastrol Attenuates the Invasion and Migration and Augments the Anticancer Effects of Bortezomib in a Xenograft Mouse Model of Multiple Myeloma.
P2860
Q21133027-94BCC043-5F3F-4E92-81F6-863F61A4698AQ28484018-F55DB177-746D-462B-9020-1FD2FCDDB263Q28484487-6602B4F1-5BD2-436C-A536-F22C9CE1F654Q28486540-A7D07E80-10DF-45D2-8E21-2A194F6601C5Q28487695-02E96EE7-7189-4006-B280-5300E7528AB1Q28538133-2A7673C8-95C3-4084-9C3A-E68DCABB0256Q34079481-FE176183-52F7-4655-BED0-83F0A873D1C9Q34482963-F7C549E1-29EF-46B9-921B-C841357EEF29Q34502573-812E1ABB-9A33-4FD8-8E33-4D1203032B21Q34628984-ED690752-D7CD-4105-BE90-7CBD649C9B6CQ35883602-FABE7DDF-B024-4C32-83B9-F0DF44CD40FFQ36191349-3D5D2DFE-5DA3-4F23-93D3-4ADCF8343B8AQ36458235-6640CBA1-AE23-4AB5-8D49-39512BDE46ECQ36655323-62800593-E2A4-46E0-B7C2-DBACBDF6B792Q37629548-859D90AE-7D13-4442-922A-E203970AE368Q37641588-7A965DED-3398-49EB-A299-3397D697DF33Q37997623-23E97846-7B8C-4A1E-BF5D-9D4C512AA9E0Q38069898-AE92A4AA-230B-414C-824C-40E970CDA8AAQ38092777-D7229C7F-399D-4DCC-8762-383E889AAA30Q38187815-A3716470-340A-4248-9E81-5A7F3E6E93F5Q38705383-6A5EEDB1-E725-48DF-86DC-69419975CCCDQ38818143-9188DF54-5676-41C3-9D19-09DB2A8674A9Q38964428-55141119-473B-443F-81A5-FB23CAFB867DQ39062936-6563BFD1-0661-4CDB-99F9-21C4D7999640Q39070877-68CDF36B-F243-49B3-BDB4-CA5DCEBDBDBEQ39144112-FDFDC522-4EA7-4F61-BA1D-DE4F5F42E0A4Q39147029-08762C13-1F70-4A3B-8688-0A2FE7A48F28Q39212503-34AD7A33-BB12-4C9A-A664-5AEA64810C05Q39268054-3AE57EAF-B1B3-47A9-84D0-1E79E6DA0A66Q39305660-4878CBED-4FF4-4804-B283-F4D2F7E5404EQ39406168-E13D1369-33B5-44DD-9589-C8485ABA67B2Q40945955-DE3D688B-B3E5-4E3E-9010-84C99D001AB8Q41016182-5DC75F88-FB28-48F9-A643-AB18499F56C7Q47171292-9E9426C2-F998-41B4-B714-18E8F32EDD3DQ47631097-2C0B7214-CE68-4E27-A80D-A5D83EF3DCB9Q51284880-7C3E50C2-0BC1-483C-92A8-35156895EC4DQ51458495-D0ADDC05-9FFF-4235-B153-DAF9AD00C844Q53118440-94AA49A1-5D66-438D-A115-951C11DEF08CQ55281764-79BFD1CE-63B8-4D1C-B832-8E6275495D94
P2860
Natural proteasome inhibitor celastrol suppresses androgen-independent prostate cancer progression by modulating apoptotic proteins and NF-kappaB
description
2010 nî lūn-bûn
@nan
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Natural proteasome inhibitor c ...... optotic proteins and NF-kappaB
@ast
Natural proteasome inhibitor c ...... optotic proteins and NF-kappaB
@en
type
label
Natural proteasome inhibitor c ...... optotic proteins and NF-kappaB
@ast
Natural proteasome inhibitor c ...... optotic proteins and NF-kappaB
@en
prefLabel
Natural proteasome inhibitor c ...... optotic proteins and NF-kappaB
@ast
Natural proteasome inhibitor c ...... optotic proteins and NF-kappaB
@en
P2093
P2860
P1433
P1476
Natural proteasome inhibitor c ...... optotic proteins and NF-kappaB
@en
P2093
Jeffrey Desano
Theodore S Lawrence
Wenhua Tang
Xiaojie Meng
P2860
P304
P356
10.1371/JOURNAL.PONE.0014153
P407
P577
2010-12-10T00:00:00Z